Furthermore, a cross-sectional analysis involving 131 elderly individuals revealed a noteworthy decrease in IGFBP-3 levels among patients with sarcopenia (49), implying a contrasting function of IGFBP-3 compared to IGF-1 in skeletal muscle. This evidence concerns the gene IGF1 and sarcopenia.